Previous report also shows that p53 silencing resulted in upregulation of p21 in CNE2 cells (25), supporting that heterozygous p53-R280T mutation gains oncogenic property in NPC cells. This evidence concerns the gene TP53 and nasopharyngeal carcinoma.